Home/Filings/4/A/0001677687-20-000001
4/A//SEC Filing

Blankenship Alex K 4/A

Accession 0001677687-20-000001

CIK 0001502152other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 11:03 AM ET

Size

10.8 KB

Accession

0001677687-20-000001

Insider Transaction Report

Form 4/AAmended
Period: 2017-04-17
Blankenship Alex K
DirectorCEO, Pres., Secr., Treas.
Transactions
  • Purchase

    Common stock

    2017-07-19$2000.00/sh+2,000,000$4,000,000,0002,500,000 total
  • Purchase

    Series E preferred stock

    2016-08-11$1000.00/sh+1,000,000$1,000,000,0001,000,000 total
  • Purchase

    Common stock

    2020-08-14$500.00/sh+5,000,000$2,500,000,00011,000,000 total
  • Purchase

    Common stock

    2017-04-17+500,000500,000 total
  • Purchase

    Common stock

    2018-12-06+3,500,0006,000,000 total
Footnotes (2)
  • [F1]The shares were issued pursuant to the Issuer's 2012 Stock Plan for Directors, Officers, and Consultants that has been registered with the SEC on Form S-8.
  • [F2]Issued for services rendered.

Issuer

AngioSoma, Inc.

CIK 0001502152

Entity typeother

Related Parties

1
  • filerCIK 0001677687

Filing Metadata

Form type
4/A
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 11:03 AM ET
Size
10.8 KB